SECTION C (continued)
21.
❒ Hepatitis, resulting in chronic liver disease
manifested by appropriate findings, (e.g., persistent
ascites, bleeding esophageal varices, hepatic
encephalopathy)
MALIGNANT
N
EOPLASMS:
22. ❒ Carcinoma of the Cervix, invasive, FIGO stage II
and beyond
23.
❒ Kaposi’s Sarcoma, with extensive oral lesions; or
involvement of the gastrointestinal tract, lungs, or
other visceral organs; or involvement of the skin or
mucous membranes with extensive fungating or
ulcerating lesions not responding to treatment
24.
❒ Lymphoma, of any type, (e.g., primary lymphoma of
the brain, Burkitt’s lymphoma, immunoblastic
sarcoma, other non-Hodgkin’s lymphoma, Hodgkin’s
disease)
25.
❒ Squamous Cell Carcinoma of the Anus
S
KIN OR M
UCOUS MEMBRANES:
26. ❒ Conditions of the Skin or Mucous Membranes,
with extensive fungating or ulcerating lesions not
responding to treatment, (e.g., dermatological
conditions such as eczema or psoriasis,
vulvovaginal or other mucosal candida, condyloma
caused by human papillomavirus, genital ulcerative
disease)
HEMATOLOGIC ABNORMALITIES:
27. ❒ Anemia (hematocrit persisting at 30 percent or
less), requiring one or more blood transfusions on
an average of at least once every two months
28.
❒ Granulocytopenia, with absolute neutrophil counts
repeatedly below 1,000 cells/mm
3
and documented
recurrent systemic bacterial infections occurring at
least three times in the last five months
29.
❒ Thrombocytopenia, with platelet counts repeatedly
below 40,000/mm
3
with at least one spontaneous
hemorrhage, requiring transfusion in the last five
months; or with intracranial bleeding in the last 12
months.
N
EUROLOGICAL ABNORMALITIES:
30. ❒ HIV Encephalopathy, characterized by cognitive or
motor dysfunction that limits function and
progresses
31.
❒ Other Neurological Manifestations of HIV
Infection, (e.g., peripheral neuropathy), with
significant and persistent disorganization of motor
function in two extremities resulting in sustained
disturbance of gross and dexterous movements, or
gait and station
HIV WASTING
S
YNDROME:
32. ❒ HIV Wasting Syndrome, characterized by
involuntary weight loss of ten percent or more of
baseline (or other significant involuntary weight loss)
and, in the absence of a concurrent illness that could
explain the findings, involving: chronic diarrhea with
two or more loose stools daily lasting for one month or
longer; or chronic weakness and documented fever
greater than 38
o
C (100.4
o
F) for the majority of
one month or longer
DIARRHEA
:
33. ❒ Diarrhea, lasting for one month or longer, resistant to
treatment, and requiring intravenous hydration,
intravenous alimentation, or tube feeding
C
ARDIOMYOPATHY:
34. ❒ Cardiomyopathy (chronic heart failure, or cor
pulmonale, or other severe cardiac abnormality not
responsive to treatment)
NEPHROPATHY:
35. ❒ Nephropathy, resulting in chronic renal failure
INFECTIONS RESISTANT TO TREATMENT OR REQUIRING
HOSPITALIZATION OR INTRAVENOUS TREATMENT THREE OR
MORE TIMES IN ONE YEAR:
36. ❒ Sepsis
37.
❒ Meningitis
38.
❒ Pneumonia (non-PCP)
39.
❒ Septic Arthritis
40.
❒ Endocarditis
41.
❒ Sinusitis, radiographically documented
NOTE: If you have checked any of the boxes in Section C, proceed to Section E to add any remarks you wish to make about this patient’s
condition. then proceed to Sections F and G and sign and date the form.
If you have not checked any of the boxes in Section C, please complete Section D. See Part VI of the Instruction Sheet for definitions of the
terms we use in Section D. Proceed to Section E if you have any remarks you wish to make about this patient’s condition. Then, proceed to
Sections F and G and sign and date the form.